Cytokine regulation of skin barrier function

细胞因子对皮肤屏障功能的调节

• 批准号: 8996670
• 负责人: MARK H KAPLAN
• 金额: $ 39万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-02-15 至 2018-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8996670
• 关键词: Address; Allergens; Allergic; Allergic Disease; Allergic inflammation; Asthma; Atopic Dermatitis; Binding; Biological Models; Biology; Cells; ChIP-seq; Complex; Coupled; Cytokine Activation; Defect; Dendritic Cells; Development; Diagnosis; Disease; Environment; Erythema; Family history of; Gene Chips; Gene Expression; Genes; Genetic; Goals; Hypersensitivity; Immune response; Immune system; Immunity; Infant; Infection; Inflammation; Interleukin-13; Interleukin-4; Missense Mutation; Modeling; Molecular; Mus; Mutation; Pathogenesis; Pathway interactions; Patients; Phenotype; Predisposing Factor; Process; Pruritus; Regulation; Role; STAT6 gene; Sampling; Skin; Swelling; Symptoms; System; T-Lymphocyte; Tail; Testing; Urticaria; base; cytokine; filaggrin; gene function; immune function; in vivo; keratinocyte; mouse model; response; skin barrier; targeted treatment

DESCRIPTION (provided by applicant): Skin inflammation in Atopic Dermatitis (AD) patients includes dendritic cells, mast cells and T cells. Evidence for the function of several T helper subsets in AD exists both from patient samples and from mouse models. There is clearly a genetic component in disease; family history of allergy is one of the strongest predictors of AD, and mutations in the filaggrin (FLG) gene, a component of the Epidermal Differentiation Complex (EDC), have emerged as a predisposing factor for the development of AD. IL-4 and IL-13 promote atopic responses and decrease expression of a number of EDC genes, which are critical for barrier function. One of the primary questions that remain unanswered is whether the defect leading to AD is in the skin, in the atopic immune system, or whether disease requires defects in both systems. Central to answering this question is an understanding of how the immune system and the skin, particularly keratinocytes, interact at the molecular level. The overall goal of this Project is to define the interactions of cytokines that promote the development of atopic inflammation on keratinocyte gene expression and function, with the long-term goal of finding pathways that could be targeted for treatment of disease. Our hypothesis is that pro-allergic cytokines change the biology of keratinocytes and alter barrier function, facilitating increased allergen exposure. This hypothesis will be examined in two Aims that will examine the interactions of filaggrin mutations with increased Th2 immunity in a mouse model system, and define the function of STAT6 in regulating keratinocyte gene expression. Together, these studies will provide a detailed understanding of the effects of cytokines produced during allergic inflammation on skin barrier function.

描述（由申请人提供）：特应性皮炎（AD）患者的皮肤炎症包括树突状细胞、肥大细胞和T细胞。从患者样本和小鼠模型中都可以找到一些辅助T细胞亚群在AD中起作用的证据。疾病中显然有遗传因素；过敏家族史是AD的最强预测因素之一，聚丝蛋白（FLG）基因突变是表皮分化复合体（EDC）的一个组成部分，已成为AD发展的一个易感因素。IL-4和IL-13促进特应性反应并降低一些EDC基因的表达，这些基因对屏障功能至关重要。其中一个尚未解决的主要问题是，导致阿尔茨海默病的缺陷是在皮肤上，还是在特应性免疫系统上，或者疾病是否需要两个系统都有缺陷。回答这个问题的核心是理解免疫系统和皮肤，特别是角质形成细胞如何在分子水平上相互作用。该项目的总体目标是确定促进特应性炎症发展的细胞因子对角化细胞基因表达和功能的相互作用，长期目标是找到可能靶向治疗疾病的途径。我们的假设是，促过敏细胞因子改变了角质形成细胞的生物学特性，改变了屏障功能，促进了过敏原暴露的增加。这一假设将在两个目标中得到验证，这两个目标将在小鼠模型系统中检测聚丝蛋白突变与Th2免疫增强的相互作用，并确定STAT6在调节角质形成细胞基因表达中的功能。总之，这些研究将提供对过敏炎症过程中产生的细胞因子对皮肤屏障功能的影响的详细了解。